120 related articles for article (PubMed ID: 15462372)
1. [Parkinson's disease: the disease concept, etiology and diagnostic bases].
Kuno S
Nihon Rinsho; 2004 Sep; 62(9):1603-7. PubMed ID: 15462372
[TBL] [Abstract][Full Text] [Related]
2. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
During MJ; Kaplitt MG; Stern MB; Eidelberg D
Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
[TBL] [Abstract][Full Text] [Related]
3. [The pathogenesis of Parkinson's disease: a hint from insights of familial Parkinson's disease].
Hattori N; Kubo S
Rinsho Shinkeigaku; 2007 Nov; 47(11):774-8. PubMed ID: 18210796
[TBL] [Abstract][Full Text] [Related]
4. Parkinson's at risk syndrome: can Parkinson's disease be predicted?
Stern MB; Siderowf A
Mov Disord; 2010; 25 Suppl 1():S89-93. PubMed ID: 20187248
[TBL] [Abstract][Full Text] [Related]
5. Parkinson's disease.
Béné R; Antić S; Budisić M; Lisak M; Trkanjec Z; Demarin V; Podobnik-Sarkanji S
Acta Clin Croat; 2009 Sep; 48(3):377-80. PubMed ID: 20055267
[TBL] [Abstract][Full Text] [Related]
6. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD
Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
[TBL] [Abstract][Full Text] [Related]
7. [Concept and diagnostic criteria of Parkinson's disease and parkinsonism].
Mizuno Y
Nihon Rinsho; 1997 Jan; 55(1):16-20. PubMed ID: 9014417
[TBL] [Abstract][Full Text] [Related]
8. Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease.
Chastan N; Westby GW; Yelnik J; Bardinet E; Do MC; Agid Y; Welter ML
Brain; 2009 Jan; 132(Pt 1):172-84. PubMed ID: 19001482
[TBL] [Abstract][Full Text] [Related]
9. Factors predicting response to dopaminergic treatment for resting tremor of Parkinson's disease.
Sung YH; Chung SJ; Kim SR; Lee MC
Mov Disord; 2008 Jan; 23(1):137-40. PubMed ID: 17987649
[TBL] [Abstract][Full Text] [Related]
10. Local field potential beta activity in the subthalamic nucleus of patients with Parkinson's disease is associated with improvements in bradykinesia after dopamine and deep brain stimulation.
Ray NJ; Jenkinson N; Wang S; Holland P; Brittain JS; Joint C; Stein JF; Aziz T
Exp Neurol; 2008 Sep; 213(1):108-13. PubMed ID: 18619592
[TBL] [Abstract][Full Text] [Related]
11. Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.
Yamada K; Goto S; Hamasaki T; Kuratsu JI
Acta Neurochir (Wien); 2008 Jan; 150(1):15-22; discussion 22. PubMed ID: 18180867
[TBL] [Abstract][Full Text] [Related]
12. Non-motor extranigral signs and symptoms in Parkinson's disease.
Wolters ECh
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S6-12. PubMed ID: 20083010
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications of Parkinson's disease genetics.
Lorincz MT
Semin Neurol; 2006 Nov; 26(5):492-8. PubMed ID: 17048150
[TBL] [Abstract][Full Text] [Related]
14. [Patterns of neuronal activity in the basal ganglia nucleus in parkinsonian patients with levodopa-induced dyskinesia].
Li XY; Zhuang P; Li YJ
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(23):1607-12. PubMed ID: 19035099
[TBL] [Abstract][Full Text] [Related]
15. Understanding Parkinson's disease: detection and early disease management.
Mackin LA
Lippincotts Prim Care Pract; 2000; 4(6):595-607. PubMed ID: 11933373
[TBL] [Abstract][Full Text] [Related]
16. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
Jellinger KA
Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
[TBL] [Abstract][Full Text] [Related]
17. Overview of Parkinson's disease.
Lew M
Pharmacotherapy; 2007 Dec; 27(12 Pt 2):155S-160S. PubMed ID: 18041935
[TBL] [Abstract][Full Text] [Related]
18. Parkinson's disease. Diagnosis and the initiation of therapy.
Bhat V; Weiner WJ
Minerva Med; 2005 Jun; 96(3):145-54. PubMed ID: 16175158
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: problems with the current model.
Obeso JA; Rodriguez-Oroz MC; Rodriguez M; DeLong MR; Olanow CW
Ann Neurol; 2000 Apr; 47(4 Suppl 1):S22-32; discussion S32-4. PubMed ID: 10762129
[TBL] [Abstract][Full Text] [Related]
20. Clinical criteria for the diagnosis of Parkinson's disease.
Reichmann H
Neurodegener Dis; 2010; 7(5):284-90. PubMed ID: 20616563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
